Patents for A61P 35 - Antineoplastic agents (221,099)
12/2010
12/21/2010CA2309326C Pharmaceutical compositions containing cyclodextrins and taxoids
12/21/2010CA2267069C Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy
12/21/2010CA2214406C Use of penciclovir for the treatment of human herpes-virus-8
12/19/2010CA2670301A1 Inhibition of metastasis using activated protein c
12/16/2010WO2010144846A2 Gastrointestinal disease or disorder imaging and treatment
12/16/2010WO2010144788A2 Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer stem cells
12/16/2010WO2010144675A1 Polymorphs of bendamustine hcl and processes for preparation thereof
12/16/2010WO2010144499A2 Urea derivatives as kinase inhibitors
12/16/2010WO2010144486A1 Dihydropyrrolonaphtyridinone compounds as inhibitors of jak
12/16/2010WO2010144468A1 2- ( lh-pyrazol-4 -ylamino ) -pyrimidine as kinase inhibitors
12/16/2010WO2010144464A2 Solid dispersions containing an apoptosis-promoting agent
12/16/2010WO2010144055A1 Novel compounds and uses thereof
12/16/2010WO2010143942A1 Targeted nano-photomedicines for photodynamic therapy of cancer
12/16/2010WO2010143708A1 Targeting agent for neovascularization
12/16/2010WO2010143664A1 Tetracyclic compound
12/16/2010WO2010143582A1 Phenylcyclopropylamine derivatives and lsd1 inhibitors
12/16/2010WO2010143435A1 Vaccine therapy for choroidal neovascularization
12/16/2010WO2010143193A1 Targeted liposomes comprising n-containing bisphosphonates and uses thereof
12/16/2010WO2010143188A2 Halogenated aliphatic carboxylic acids, oligomers and/or polymers thereof and their use in devitalizing external and internal neoplasms
12/16/2010WO2010143020A1 Therapeutical use of ternary complexes of valproic acid
12/16/2010WO2010142994A1 2, 3-dihydro-1h-indene compounds and their use to treat cancer
12/16/2010WO2010142925A1 Use of alkylglycerols for preparing drugs
12/16/2010WO2010142779A1 Antifungal 1,2,4-triazolyl derivatives having a 5- sulfur substituent
12/16/2010WO2010142735A1 Pyridinyl derivatives as inhibitors of enzyme nicotinamide phosphoribosyltransferase
12/16/2010WO2010142426A1 Hedgehog pathway antagonists and therapeutic applications thereof
12/16/2010WO2010142258A1 Production and use of antitumoral, antibiotic and insecticidal cyclodepsipeptides
12/16/2010WO2010142124A1 New uses of medicines with adamantane structure and their derivatives and analogues in treating tumor-related diseases
12/16/2010WO2010142040A1 Novel netrin derivatives and uses thereof
12/16/2010WO2010142007A1 Pharmaceutical composition and use of the pharmaceutical composition for the treatment, prophylaxis or prevention of neoplastic diseases in humans and animals
12/16/2010WO2010141986A1 Novel antibodies and uses therefor
12/16/2010WO2010141985A1 Methods of treatment
12/16/2010WO2010100404A3 Rna molecules and therapeutic uses thereof
12/16/2010WO2010071852A3 Oligonucleotide micelles
12/16/2010WO2009129281A3 Compositions and methods for delivering inhibitory oligonucleotides
12/16/2010US20100319073 GDE Compositions and Methods
12/16/2010US20100317865 Enzyme and receptor modulation
12/16/2010US20100317826 Neoplasm specific antibodies and uses thereof
12/16/2010US20100317740 Method for Predicting Response to Tamoxifen
12/16/2010US20100317739 Histone deacetylase inhibitors
12/16/2010US20100317732 Method of inhibiting abcg2 and other treatment methods
12/16/2010US20100317726 Slco1b3 genotype
12/16/2010US20100317724 Method for searching for homing endonucleases, their genes and their targets
12/16/2010US20100317723 Nucleolin Specific Aptamer and Use thereof
12/16/2010US20100317722 NUCLEIC ACID SEQUENCES COMPRISING NF-kB BINDING SITE WITHIN O(6)-METHYLGUANINE-DNA-METHYLTRANSFERASE (MGMT) PROMOTER REGION AND USES THEREOF FOR THE TREATMENT OF CANCER AND IMMUNE-RELATED DISORDERS
12/16/2010US20100317721 Compositions and Methods for Treating Tumors, Fibrosis, and Pulmonary Alveolar Proteinosis
12/16/2010US20100317720 Methods and Compositions for the Treatment of Intestinal Conditions
12/16/2010US20100317718 Modulation of hif1 beta expression
12/16/2010US20100317717 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/16/2010US20100317712 Estrogen Agonists/Antagonists For Preventing Breast Cancer
12/16/2010US20100317710 3-(3-indolyl) propionic acid calcium salt and method of making 3-(3-indolyl) propionic acid free acid therefrom
12/16/2010US20100317709 Sphingosine-1-phosphate (s1p) receptor compounds
12/16/2010US20100317708 Carcinoma diagnosis and treatment, based on odc1 genotype
12/16/2010US20100317706 HNF4alpha MODULATORS AND METHODS OF USE
12/16/2010US20100317688 2-HETEROAROYLIMIDAZOL[1,2-a]PYRIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
12/16/2010US20100317687 2-BENZOYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
12/16/2010US20100317686 N-HETEROCYCLIC-6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
12/16/2010US20100317685 N-PHENYL-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
12/16/2010US20100317684 Amide and Carbamate Derivatives of N-{2-[4-Amino-2- (Ethoxymethyl)-1H-Imidazo[4,5-c] Quinolin-1-Yl]-1,1-Dimethylethyl} Methanesulfonamide and Methods
12/16/2010US20100317680 Pyrimidine inhibitors of kinases
12/16/2010US20100317678 Hydroxamates as inhibitors of histone deacetylase
12/16/2010US20100317675 6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
12/16/2010US20100317673 N-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
12/16/2010US20100317667 1-aryl-or 1-heteroaryl-pyrido[B]indoles and uses thereof
12/16/2010US20100317665 Anti-Inflammatory And Protein Kinase Inhibitor Compositions And Related Methods For Downregulation Of Detrimental Cellular Responses And Inhibition Of Cell Death
12/16/2010US20100317663 Anilinopyridines as inhibitors of fak
12/16/2010US20100317661 Small molecule inhibitors of mdm2 and the uses thereof
12/16/2010US20100317659 Jak kinase modulating compounds and methods of use thereof
12/16/2010US20100317658 4,7-Dioxobenzothiazole-2-Carboxamide Derivatives, Their Preparation And Their Therapeutic Uses
12/16/2010US20100317657 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES
12/16/2010US20100317656 IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPEUTICS
12/16/2010US20100317649 S1P Receptor Modulating Compounds and Use Thereof
12/16/2010US20100317647 Novel cyclopentane derivatives
12/16/2010US20100317646 Compounds
12/16/2010US20100317644 Substituted Sulfonamide Compounds
12/16/2010US20100317641 Thiazoles and pyrazoles useful as kinase inhibitors
12/16/2010US20100317635 Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
12/16/2010US20100317628 MicroRNA Modulators and Method for Identifying and Using the Same
12/16/2010US20100317620 N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE COMPOUNDS, PREPARATION AND THERAPEUTIC USE THEREOF
12/16/2010US20100317618 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1 and cx3cr1
12/16/2010US20100317610 Methods and Compositions for Inducing Deregulation of EPHA7 and ERK Phosphorylation in Human Acute Leukemias
12/16/2010US20100317606 Novel triterpenes for modulating gene expression and cell membrane, and as antiprotozoal agents
12/16/2010US20100317603 Treatment of Cancer and Inflammatory Disorder
12/16/2010US20100317598 Isolated BRCA1 Peptides and Method of Use
12/16/2010US20100317594 Methods for treating breast cancer using NRIF3 related molecules
12/16/2010US20100317593 2,3-dihydro-1h-indene compounds
12/16/2010US20100317592 Chemokine-binding protein and methods of use
12/16/2010US20100317590 Regulation of skin characteristics by dickkopf1 (dkk1)
12/16/2010US20100317583 Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (hsaa)
12/16/2010US20100317580 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
12/16/2010US20100317566 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
12/16/2010US20100317563 Methods for modulating the proliferation and differentiation potential of stem cells and progenitor cells
12/16/2010US20100317518 Meadowfoam-based bioherbicide products
12/16/2010US20100317003 Novel compositions and methods in cancer with altered expression of kcnj9
12/16/2010US20100316740 Compositions for the treatment of benign prostate hypertrophy, prostatitis, prostatosis and prostate cancer
12/16/2010US20100316734 Methods of thermograph-guided medical treatment
12/16/2010US20100316733 Hyperbaric Oxygen Therapy and Treatment Method
12/16/2010US20100316718 Activated foam
12/16/2010US20100316706 Carbocyclic and oxacarbocyclic fumaric acid oligomers
12/16/2010US20100316703 Rna interference mediating small rna molecules
12/16/2010US20100316699 Compositions and Methods for Inhibiting Viral Replication